论文部分内容阅读
目的探讨鼻塞持续气道正压通气(NCPAP)治疗早产儿原发性反复呼吸暂停的疗效及临床价值。方法将反复呼吸暂停的30例早产儿为治疗组,应用NCPAP辅助呼吸,并与30例未使用NCPAP的反复呼吸暂停的早产儿进行回顾性临床对照分析。结果治疗组应用NCPAP后显效率及总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论NCPAP治疗早产儿反复呼吸暂停,可改善临床症状和血气指标,缩短氧疗时间和住院天数,降低呼吸衰竭、肺部感染、高胆红素血症及其他临床并发症的发生率。
Objective To investigate the efficacy and clinical value of nasal continuous positive airway pressure (NCPAP) in the treatment of premature infants with primary recurrent apnea. Methods Thirty premature infants with repeated apnea were treated by NCPAP. Thirty patients with preterm infants without repetitive apnea of NCPAP were retrospectively analyzed. Results After treatment with NCPAP, the apparent effective rate and total effective rate in the treatment group were significantly higher than those in the control group (P <0.05). Conclusion NCPAP treatment of premature infants with repeated apnea can improve the clinical symptoms and blood gas indexes, shorten the duration of oxygen therapy and hospital stay, reduce the incidence of respiratory failure, pulmonary infection, hyperbilirubinemia and other clinical complications.